Primary PCI in Elderly STEMI Patients: Risk Assessment and Management

Samiullah; Hameed Ullah; Abdul Waris; Muhammad Niaz Khan; Nazeef Ullah; Abid Ullah

doi:10.70749/ijbr.v2i02.415

Authors

Samiullah Department of Cardiology, MTI - Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Hameed Ullah Department of Cardiology, MTI - Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Abdul Waris Department of Cardiology, MTI - Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Muhammad Niaz Khan Department of Cardiology, MTI - Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Nazeef Ullah Department of Cardiology, MTI - Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Abid Ullah Department of Cardiology, MTI - Hayatabad Medical Complex, Peshawar, KP, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v2i02.415

Keywords:

STEMI, Frailty, Primary PCI, Elderly Patients, Clinical Outcomes

Abstract

Objective: To evaluate the impact of frailty on clinical and procedural outcomes in elderly STEMI patients undergoing primary percutaneous coronary intervention (PCI) at Hayatabad Medical Complex, Peshawar. Methodology: A retrospective study was conducted from April 2023 to March 2024, including 300 patients aged ≥65 years divided equally into frail and non-frail groups (n=150 each). Data were collected on demographic characteristics, procedural outcomes, and complications. Statistical analysis included chi-square tests for categorical variables and t-tests for continuous variables, with a significance level of p<0.05. Results: The mean Killip class was significantly higher in frail patients (2.5 ± 0.8) compared to non-frail patients (1.8 ± 0.5; p<0.05). Symptom onset-to-treatment time was longer among frail patients (7.4 ± 2.1 hours vs. 5.8 ± 1.9 hours; p<0.05). TIMI grade 3 flow was achieved in 82% of non-frail patients compared to 65% in frail patients (p<0.05). Major adverse cardiac events (MACE) occurred in 42% of frail patients versus 18% of non-frail patients (p<0.05). ST-segment resolution was achieved in 78% of non-frail patients compared to 54% in frail patients (p<0.05). Conclusion: Frailty significantly impacts clinical and procedural outcomes in elderly STEMI patients, highlighting the need for tailored approaches to improve treatment and post-PCI care. Future studies should validate these findings in broader populations and explore advanced strategies to address frailty.

Downloads

Download data is not yet available.

References

Hermans, M. P., Eindhoven, D. C., Van Winden, L. A., De Grooth, G. J., Blauw, G. J., Muller, M., & Schalij, M. J. (2019). Frailty score for elderly patients is associated with short-term clinical outcomes in patients with ST-segment elevated myocardial infarction treated with primary percutaneous coronary intervention. Netherlands Heart Journal, 27(3), 127-133. https://doi.org/10.1007/s12471-019-1240-7

Seif, S., Salama, M., Elsaeid, A., Zaki, A., & Badr, S. (2022). Assessment of primary percutaneous coronary intervention outcomes in elderly and very elderly patients. Journal of Advances in Medicine and Medical Research, 113-124. https://doi.org/10.9734/jammr/2022/v34i1931445

Jariwala, P., & Jadhav, K. (2022). Primary PCI in the very elderly: A study of outcomes in patients aged > 85 years with STEMI. European Heart Journal, 43(Supplement_1). https://doi.org/10.1093/eurheartj/ehab849.076

Zubair, M., Salam, A., Zaman, Q., Latif, A., Deep, A., & Ahmed, S. (2024). Clinical profile and outcomes of primary PCI in patients with acute STEMI. Pakistan Journal of Medical and Health Sciences, 17(5), 684-687. https://doi.org/10.53350/pjmhs2023175684

Savic, L., Mrdovic, I., Asanin, M., Stankovic, S., Krljanac, G., & Lasica, R. (2019). Using the RISK-PCI score in the long-term prediction of major adverse cardiovascular events and mortality after primary percutaneous coronary intervention. Journal of Interventional Cardiology, 2019, 1-9. https://doi.org/10.1155/2019/2679791

Szabo, D., Szabo, A., Magyar, L., Banhegyi, G., Kugler, S., Pinter, A., Juhasz, V., Ruppert, M., Olah, A., Ruzsa, Z., Edes, I. F., Szekely, A., Becker, D., Merkely, B., & Hizoh, I. (2022). Admission lactate level and the GRACE 2.0 score are independent and additive predictors of 30-day mortality of STEMI patients treated with primary PCI—Results of a real-world registry. PLOS ONE, 17(11), e0277785. https://doi.org/10.1371/journal.pone.0277785

Roguin, A. (2020). Clinical practice and outcomes in elderly STEMI patients undergoing PCI with new generation DES – data from a large worldwide registry. European Heart Journal, 41(Supplement_2). https://doi.org/10.1093/ehjci/ehaa946.1777

AKBER, S., ABDULLAH, .., & KHAN, F. (2024). Gender differences in clinical outcomes among stemi patients undergoing primary pci. Biological and Clinical Sciences Research Journal, 2024(1), 1143. https://doi.org/10.54112/bcsrj.v2024i1.1143

Li, M., Zeng, D., Zhou, Y., Chen, J., Cao, S., Song, H., Hu, B., Yuan, W., Chen, J., Yang, Y., Wang, H., Fei, H., Shi, Y., & Zhou, Q. (2023). A novel risk stratification model for STEMI after primary PCI: Global longitudinal strain and deep neural network assisted myocardial contrast echocardiography quantitative analysis. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1140025

Leivo, J., Anttonen, E., Jolly, S. S., Dzavik, V., Koivumaki, J., Tahvanainen, M., Koivula, K., Nikus, K., Wang, J., Cairns, J. A., Niemela, K., & Eskola, M. J. (2018). P3680The high-risk ECG pattern of ST-elevation myocardial infarction: A substudy of the randomized trial of primary PCI with or without routine manual thrombectomy (TOTAL trial). European Heart Journal, 39(suppl_1). https://doi.org/10.1093/eurheartj/ehy563.p3680

Milasinovic, D., Nedeljkovic, O., Maksimovic, R., Sobic-Saranovic, D., Dukic, D., Zobenica, V., Jelic, D., Zivkovic, M., Dedovic, V., Stankovic, S., Asanin, M., & Vukcevic, V. (2023). Coronary microcirculation: The next frontier in the management of STEMI. Journal of Clinical Medicine, 12(4), 1602. https://doi.org/10.3390/jcm12041602

Van de Werf, F., Ristić, A. D., Averkov, O. V., Arias-Mendoza, A., Lambert, Y., Kerr Saraiva, J. F., Sepulveda, P., Rosell-Ortiz, F., French, J. K., Musić, L. B., Vandenberghe, K., Bogaerts, K., Westerhout, C. M., Pagès, A., Danays, T., Bainey, K. R., Sinnaeve, P., Goldstein, P., & Welsh, R. C. (2023). STREAM-2: Half-dose Tenecteplase or primary percutaneous coronary intervention in older patients with ST-segment–elevation myocardial infarction: A randomized, open-label trial. Circulation, 148(9), 753-764. https://doi.org/10.1161/circulationaha.123.064521

Yang, L., Cong, H., Lu, Y., Chen, X., & Liu, Y. (2021). A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction. Annals of Translational Medicine, 9(2), 126-126. https://doi.org/10.21037/atm-20-8003

Fazeel, H. M., Malik, S. U., Ranjha, S., Yousaf, A., Yousaf, H., & Salah Ud Din, E. (2023). Abstract 16311: Differential outcomes of primary percutaneous coronary intervention compared to medical management alone for very elderly patients with ST-elevation and Non-ST-Elevation myocardial infarctions - A systematic review and meta-analysis. Circulation, 148(Suppl_1). https://doi.org/10.1161/circ.148.suppl_1.16311

Li, S., Zhang, X., Zhou, G., & Wang, J. (2019). Delirium after primary percutaneous coronary intervention in aged individuals with acute ST segment elevation myocardial infarction: A retrospective study. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2019.7398